Bris­tol My­ers touts ear­ly so­cial and en­vi­ron­men­tal progress among achieve­ments in lat­est ESG re­port

A boost for di­ver­si­ty in clin­i­cal tri­als and an ear­li­er-than-ex­pect­ed $1 bil­lion spend with mi­nor­i­ty-owned busi­ness­es are some of the high­lights in Bris­tol My­ers Squibb’ …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER